COMMUNIQUÉS West-GlobeNewswire

Oncolytics Biotech® Establishes New At-The-Market Facility
25/10/2018
CALGARY, Alberta and SAN DIEGO, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus that turns cold [...]
LeMaitre Vascular Acquires Cardial Business of BD
24/10/2018
BURLINGTON, Mass., Oct. 24, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), announced today that it has acquired the assets of Cardial, a subsidiary of BD (Becton, Dickinson & Company), located in [...]
Supernus to Host Third Quarter 2018 Earnings Conference Call
24/10/2018
ROCKVILLE, Md., Oct. 24, 2018 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous [...]
MyoKardia Doses First Patient in MAVA Long-Term Extension Study of Mavacamten for Hypertrophic Cardiomyopathy
24/10/2018
Key Remaining Study in Registration Program for oHCM Enables Assessment of Mavacamten’s Potential for Disease Modification SOUTH SAN FRANCISCO, Calif., Oct. 24, 2018 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), a [...]
Align Technology Announces Third Quarter 2018 Financial Results
24/10/2018
Q3 revenues up 31.2% year-over-year to a record $505.3 million, and diluted EPS of $1.24 Q3 operating income up 26.8% year-over-year to $125.2 million, operating margin of 24.8% Q3 total Invisalign case shipments up 35. [...]
Sarepta Therapeutics Announces Third Quarter 2018 Financial Results and Recent Corporate Developments
24/10/2018
-- Third quarter 2018 EXONDYS 51® (eteplirsen) total net revenues of $78.5 million -- CAMBRIDGE, Mass., Oct. 24, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a leader in precision genetic medicine [...]
Intercept to Announce Third Quarter 2018 Financial Results on October 31, 2018
24/10/2018
NEW YORK, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non- [...]
OrthoPediatrics Corp. to Report Third Quarter 2018 Financial Results on October 31, 2018
24/10/2018
Conference Call to Discuss Results on November 1, 2018 at 8:00 a.m. ET WARSAW, Ind., Oct. 24, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), an orthopedic company focused exclusively [...]
MRI Interventions Congratulates Monteris Medical on FDA Clearance of NeuroBlate Laser Probe
24/10/2018
Clearance Resolves Outstanding FDA Advisory Notice Issues IRVINE, Calif., Oct. 24, 2018 (GLOBE NEWSWIRE) -- MRI Interventions (OTCQB:MRIC) congratulates Monteris Medical on the FDA Clearance of its new NeuroBlate Optic [...]
Hallmark third quarter 2018 and Annual R&D Update at Galapagos
24/10/2018
First nine months financial results: Group revenues increased by €98.7 million to €205.1 million Operating loss decreased by €9.1 million to €53.5 million Net loss decreased by €41.7 million to €44.2 million Cash and [...]
Galapagos and AbbVie restructure CF collaboration
24/10/2018
Mechelen, Belgium, Chicago, US; 24 October 2018; 22.02 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) and AbbVie, Inc (NYSE: ABBV) announce a restructuring of their cystic fibrosis (CF) alliance [...]
Topline interim results of FALCON trial Part 1 in CF
24/10/2018
Mechelen, Belgium; 24 October 2018; 22.01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announces topline interim results of Part 1 of the FALCON trial in cystic fibrosis (CF). The FALCON trial [...]
Genesis HealthCare Expects to Release Third Quarter 2018 Results on November 7, 2018
24/10/2018
KENNETT SQUARE, Pa., Oct. 24, 2018 (GLOBE NEWSWIRE) -- Genesis HealthCare (NYSE:GEN) (Genesis or the Company), one of the nation’s largest providers of post-acute care, today announced that it expects to release its [...]
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Nine Months Ended September 30, 2018
24/10/2018
SAN DIEGO, Oct. 24, 2018 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve [...]
Emergent BioSolutions to Offer All Public Libraries and YMCAs in the U.S. Free Opioid Awareness Education and NARCAN® (naloxone HCl) Nasal Spray
24/10/2018
New initiatives make free doses and educational materials available to thousands of public libraries & YMCAs in the U.S. GAITHERSBURG, Md., Oct. 24, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) [...]
SPINEWAY : 2018 half-year results - Revenue for first nine months at €4.8M - Moving forward in the US
24/10/2018
2018 half-year results Revenue for first nine months at €4.8M Moving forward in the US In thousands of euros Consolidated accounts HY1 2018 H1 2017 Revenue 3 352 6 016 Gross margin % revenue 2 214 66.1 % 4 122 68.5 % [...]
SPINEWAY : Résultats semestriels 2018 - Chiffre d'affaires à 9 mois de 4,8 M€ - Accélération aux États-Unis
24/10/2018
Résultats semestriels 2018 Chiffre d'affaires à 9 mois de 4,8 M€ Accélération aux États-Unis En Milliers d'euros Comptes consolidés S1 2018 S1 2017 Chiffre d'affaires 3 352 6 016 Marge Brute % CA 2 214 66,1 % 4 122 68,5 [...]
Cognition Therapeutics to Sponsor Third International Symposium on Sigma-2 Receptors: Role in Health and Disease during the Society for Neuroscience Annual Meeting
24/10/2018
Pittsburgh, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. , a clinical stage neuroscience company focused on synaptic protection and restoration in Alzheimer’s disease and other neurodegenerative [...]
Company statement
24/10/2018
Allschwil, Switzerland - October 24, 2018 Idorsia Ltd (SIX: IDIA) today announced that a representative of former Axovan shareholders claims the demerger of Actelion and Idorsia would trigger the acceleration of all [...]

Pages